News

The company has signed a deal with Menarini for Turkey market, which has been already marketing TMX-67 under the brand name Adenuric in Europe since March 2010 under

The study is a randomized, double-blinded, controlled study of tivantinib plus erlotinib, versus placebo plus erlotinib in patients who have received prior treatment for advanced, non-squamous NSCLC. The

The study was conducted at 23 centers in the US and compared two doses of BC-3781 with Vancomycin in 207 patients with ABSSSI. In the study, BC-3781 demonstrated

Venlafaxine Hydrochloride Extended-release capsules 37.5mg, 75mg and 150mg are generic equivalent of Wyeth Pharmaceuticals’ Effexor XR capsules 37.5mg, 75mg and 150mg. Aurobindo Pharma received tentative approval from the

TASQ binds to a molecule called S100A9 which is expressed in the white blood cells involved in the regulation of immune responses. As per the terms of the

Liprotamase is an oral, non-porcine (not made from harvesting the pancreas of pigs), biotechnology-derived, pancreatic enzyme replacement therapy (PERT) developed to treat patients with EPI associated with cystic

The company has posted a net loss of $37.32m for the first quarter 2011, or $0.26 loss per diluted share, compared to net loss of $38.2m, or $0.27

Earlier in September 2007, Keryx sublicensed the exclusive rights for the development and commercialization of hyperphosphatemia drug Zerenex (ferric citrate) to JT and Torii in Japan. As a

The FDA has also granted the its request for priority review of its BLA. Under priority review, the target date for an FDA decision on the VEGF Trap-Eye